Last reviewed · How we verify
NCT03309488: BAT2
Basophil Activation Test to Diagnose Food Allergy
trial testing Oral food challenge in Food Allergy in 600 participants. Status unknown.
31 July 2021
Quick facts
| Lead sponsor | King's College London |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 600 |
| Start date | 30 January 2018 |
| Primary completion | 31 July 2021 |
| Estimated completion | 31 July 2021 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Oral food challenge
Conditions studied
- Food Allergy — all drugs for Food Allergy →
- Food Allergy in Infants — all drugs for Food Allergy in Infants →
- Food Allergy in Children — all drugs for Food Allergy in Children →
- Food Allergen Sensitisation — all drugs for Food Allergen Sensitisation →
Sponsor
King's College London
Who can join
Adults 6 Months to 16, any sex, with Food Allergy or Food Allergy in Infants. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The BAT II Study is a cross-sectional diagnostic study in which children with suspected IgE-mediated allergy to foods (namely cow's milk, egg, sesame and cashew), as defined by a history of an immediate-type allergic reaction to a food or no history of food consumption or the presence of food-specific IgE as documented by skin prick test or serum specific IgE, will undergo a diagnostic work-up to confirm or refute the diagnosis of IgE-mediated food allergy. Participants will be prospectively recruited from specialised Paediatric Allergy clinics in London and will undergo skin prick testing (SPT), specific IgE testing to allergen extracts and allergen components, basophil activation test (BAT) and oral food challenge. The diagnostic accuracy of the BAT and of other allergy tests will be assessed against the clinical gold-standard.
Publications & conference data
7 peer-reviewed publications reference this trial (live from Europe PMC):
-
Diagnostic utility of allergy tests to predict baked egg and lightly cooked egg allergies compared to double-blind placebo-controlled food challenges.
Krawiec M, Radulovic S, Foong RX, Marques-Mejias A, et al · · 2023 · cited 25× · PMID 37417650 · DOI 10.1111/all.15797 -
Basophil activation test as predictor of severity and threshold of allergic reactions to egg.
Radulovic S, Foong RX, Bartha I, Marques-Mejias A, et al · · 2024 · cited 20× · PMID 37680143 · DOI 10.1111/all.15875 -
Specific IgE as the best predictor of the outcome of challenges to baked milk and baked egg.
De Boer R, Cartledge N, Lazenby S, Tobias A, et al · · 2020 · cited 15× · PMID 31726233 · DOI 10.1016/j.jaip.2019.10.039 -
The evolution of nutritional care in children with food allergies - With a focus on cow's milk allergy.
Meyer R, Groetch M, Santos A, Venter C. · · 2025 · cited 7× · PMID 39587736 · DOI 10.1111/jhn.13391 -
Partial Egg Consumption Modifies the Diagnostic Performance of Allergy Tests to Predict Outcome of Double-Blind Placebo-Controlled Food Challenges to Egg.
Marques-Mejias A, Radulovic S, Foong RX, Bartha I, et al · · 2024 · cited 6× · PMID 38157981 · DOI 10.1016/j.jaip.2023.12.036 -
The Basophil Activation Test Is the Most Accurate Test in Predicting Allergic Reactions to Baked and Fresh Cow's Milk During Oral Food Challenges.
Bartha I, Boyd H, Foong RX, Krawiec M, et al · · 2025 · cited 2× · PMID 40808324 · DOI 10.1111/all.16675 -
Basophil Activation Test as Biomarker of Severity and Threshold of Allergic Reactions to Cow's Milk During Oral Food Challenges.
Boyd H, Bartha I, Foong RX, Krawiec M, et al · · 2026 · PMID 41410184 · DOI 10.1111/all.70175
Verify or expand the search:
- PubMed search for NCT03309488
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Oral food challenge
Trials testing the same drug.
- NCT06038019 — Thresholds In Food Allergy evaluaTion And predictioN · recruiting
Other recruiting trials for Food Allergy
Currently open trials in the same condition.
- NCT07210320 — PK/PD Study of IN-001 Sublingual Spray in Healthy Adults · Phase 1 · recruiting
- NCT06943534 — Omalizumab Weight-Based Dosing Efficacy Trial · Phase 2 · recruiting
- NCT06872996 — Trophallergen Prick Tests (PT) : Influence of Food Sample Shelf Life on the Reproducibility of PT Results · NA · recruiting
- NCT06529913 — Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases · NA · recruiting
- NCT06558526 — Pectin Intervention Study and Long-term Follow-up in Lipid Transfer Proteins Allergic Patients · NA · recruiting
Other King's College London trials
Trials by the same sponsor.
- NCT07357064 — Professional Decision Making in Childbirth. · not yet recruiting
- NCT07341087 — Skin Inflammation in Perimenopause: A Probiotic Intervention Proof of Concept Trial · NA · recruiting
- NCT07228962 — Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies · not yet recruiting
- NCT07365722 — Comparison of Two Non-surgical Procedure to Manage Gum Disease Around Implants. · NA · not yet recruiting
- NCT07378488 — Dance/Movement Therapy for Functional Neurological Disorder · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03309488 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by King's College London
- Last refreshed: 2 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03309488.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing